Melatonin Pharma Nord

Melatonin, the active ingredient in Melatonin Pharma Nord, is a melatonin receptor agonist presented as an oral tablet for oral use. It assists in aligning the body’s circadian rhythm and is employed to manage insomnia, other sleep disorders, and jet lag in adults and adolescents.

GNH USA supplies Melatonin Pharma Nord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing and regulatory‑aligned distribution for this sleep‑aid product.

Melatonin acts on melatonin receptors to support the regulation of the sleep‑wake cycle.

Insomnia: improves sleep onset and maintenance in individuals with difficulty falling or staying asleep. Sleep disorders: helps normalize circadian rhythm disturbances such as delayed sleep phase. Jet lag: reduces the time required to adjust to new time zones after rapid travel.

Melatonin may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Drowsiness - Headache - Dizziness - Nausea - Vivid dreams - Gastrointestinal discomfort

Serious or Rare Side Effects: - Allergic reaction (rash, itching, swelling) - Mood changes (depression, irritability) - Hormonal effects (altered menstrual cycle) - Severe hypersensitivity (anaphylaxis) - Suicidal thoughts (rare) - Severe hypotension (very rare)

Consider the following precautions when using Melatonin Pharma Nord.

Assess underlying sleep disorder: confirm diagnosis before initiating therapy. Avoid use with shift‑work schedules unless medically advised. Monitor in patients with depression: melatonin may influence mood. Caution in hepatic impairment: metabolism may be reduced. Pregnancy and breastfeeding: safety not established; use only if benefit outweighs risk. Store at ambient temperature below 25°C: keep in original container, protect from moisture and light.

Melatonin can interact with several medicines; awareness of the interaction level is important.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): may increase bleeding risk. - Immunosuppressants (e.g., cyclosporine): may reduce efficacy. - Sedatives (e.g., benzodiazepines): additive CNS depression. - Antidepressants (e.g., fluoxetine): possible serotonin syndrome.

Moderate Interactions (Monitor Closely): - Caffeine: may counteract sleep‑promoting effect. - Oral contraceptives: may alter melatonin metabolism. - Antihypertensives: potential additive hypotensive effect.